Home › Funds › Empery Asset Management, LP › NRSNW

Empery Asset Management, LP position in NRSNW

NEUROSENSE THERAPEUTICS LTD · Health Care

Empery Asset Management, LP reported holding 95,499 shares of NRSNW (NEUROSENSE THERAPEUTICS LTD) in its Q3 2026 13F filing — a position valued at US$4K, representing 0.00% of its reported portfolio and ranking #32 among its reported holdings. Empery Asset Management, LP has disclosed NRSNW holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)95.50K sh
Reported value held$4.30K
Portfolio Weight0.00%
First reportedQ4 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Empery Asset Management, LP's NRSNW position evolved

Empery Asset Management, LP first disclosed a stake in NRSNW in Q4 2025 at 100,402 shares (US$36K). Across 4 filings, Empery Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 95,499 shares valued at US$4K — a reduction of -4,903 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 100.40K $36.15K New
Q1 2026 100.40K $20.08K Hold
Q2 2026 100.40K $6.33K Hold
Q3 2026 95.50K $4.30K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRSNW and 13F data

NRSNW (NEUROSENSE THERAPEUTICS LTD) is a Health Care company. 2 other funds we track also report a position in NRSNW. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRSNW

No other tracked fund reports a position in NRSNW.

All NRSNW fund holders →

FAQ

How long has Empery Asset Management, LP held NRSNW?

Empery Asset Management, LP has disclosed NRSNW holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Empery Asset Management, LP's current position in NRSNW?

As of Q3 2026, Empery Asset Management, LP holds 95.50K shares of NRSNW (NEUROSENSE THERAPEUTICS LTD), valued at $4.30K, representing 0.00% of its reported portfolio and ranking #32.

Has Empery Asset Management, LP been buying or selling NRSNW?

In the latest 13F filing (Q3 2026), Empery Asset Management, LP reduced its position in NRSNW.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.